Department of Orthopedics and Traumatology, Umraniye Education and Research Hospital, Istanbul, Turkey.
Department of Orthopedics and Traumatology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey.
J Orthop Sci. 2021 Sep;26(5):804-811. doi: 10.1016/j.jos.2020.08.011. Epub 2020 Sep 20.
The purpose of this prospective randomized study was to compare a new reverse sugar tong splint technique with a below-arm cast, in terms of patient radiological and clinical outcomes.
One hundred and forty patients who presented to our clinic between April 2017 and March 2019 were randomly divided into two groups: 70 received reverse sugar tong (RST group) and 70 received below arm cast (BAC group). Clinical and radiological follow-up was performed 7-10 days, three weeks, 5 or 6 weeks, 12 weeks and one year after the treatment. Clinical outcomes including wrist range of motion, complication rates, Health Assessment Questionnaire (HAQ) score at end of treatment, Disabilities of the Arm, Shoulder, and Hand (Q-DASH) questionnaire and Mayo Elbow Performance score (MEPS) score at 12 weeks and last follow-up.
Finally, sixty-five patients were treated with BAC, and their average age was 58.2 years and sixty-two patients with an average age of 57.4 years were treated with RST were completed the radiological and clinical one-year follow-up. There were no significant differences in range of motion, radiological parameters, the Q-DASH and MEPS scores between the groups the 12th week and last visit; however, the HAQ score was significantly higher in the cast group during the 6th visit (p < 0.001). The BAC group had a higher complication rate (40%) than the RST group (19.3%) (p = 0.01).
Patient treated with RST had a higher functional status at end of treatment and lower complications when comparing traditional below arm cast.
Level I prognostic randomized controlled trial.
本前瞻性随机研究的目的是比较新型反糖叉夹板技术与前臂石膏固定在患者影像学和临床结果方面的差异。
2017 年 4 月至 2019 年 3 月期间,我们将 140 名患者随机分为两组:70 名患者接受反糖叉夹板(RST 组)治疗,70 名患者接受前臂石膏固定(BAC 组)。在治疗后 7-10 天、3 周、5 或 6 周、12 周和 1 年进行临床和影像学随访。临床结果包括腕关节活动范围、并发症发生率、治疗结束时的健康评估问卷(HAQ)评分、手臂、肩部和手残疾问卷(Q-DASH)评分和 12 周和最后随访时的 Mayo 肘功能评分(MEPS)评分。
最终,65 名患者接受 BAC 治疗,平均年龄为 58.2 岁,62 名患者接受 RST 治疗,平均年龄为 57.4 岁,完成了影像学和临床为期 1 年的随访。两组在第 12 周和最后一次随访时的活动范围、影像学参数、Q-DASH 和 MEPS 评分均无显著差异;然而,在第 6 次随访时,石膏组的 HAQ 评分显著更高(p<0.001)。BAC 组的并发症发生率(40%)高于 RST 组(19.3%)(p=0.01)。
与传统的前臂石膏固定相比,使用 RST 治疗的患者在治疗结束时具有更高的功能状态,且并发症发生率更低。
I 级预后随机对照试验。